Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
May 16, 2019 Off

Phase III Study Results for HP-3070 (Asenapine) Transdermal Patch for the Treatment of Schizophrenia to be Presented at the Society of Biological Psychiatry 74th Annual Meeting

By BusinessWire

— New Drug Application for investigational product HP-3070 under FDA review — MIAMI & JERSEY CITY, N.J.–(BUSINESS WIRE)–Noven Pharmaceuticals, Inc.,…

May 16, 2019 Off

bluebird bio to Present New Data from Clinical Studies of LentiGlobin™ Gene Therapy for Transfusion-Dependent β-thalassemia (TDT) and LentiGlobin Gene Therapy for Sickle Cell Disease (SCD) at the 24th EHA Congress

By BusinessWire

Additional follow-up from the completed Phase 1/2 Northstar (HGB-204) study of LentiGlobin in adolescents and adults with TDT New data…

May 16, 2019 Off

Altasciences and WuXi AppTec Enter Into Collaboration for WIND Projects

By BusinessWire

LAVAL, Quebec–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/Altasciences?src=hash" target="_blank"gt;#Altascienceslt;/agt;–Altasciences, a mid-size CRO specializing in a flexible, innovative approach to providing comprehensive early stage drug…

May 16, 2019 Off

Virta Health Partners with U.S. Department of Veterans Affairs to Help Veterans with Type 2 Diabetes

By BusinessWire

Partnership creates promise for improving the health of those living with this debilitating and costly disease SAN FRANCISCO–(BUSINESS WIRE)–Virta Health,…

May 16, 2019 Off

Lonza chooses Synpromics’ novel inducible promoter platform to manufacture biopharmaceuticals

By BusinessWire

EDINBURGH, Scotland–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/PromPT?src=hash" target="_blank"gt;#PromPTlt;/agt;–Synpromics Ltd, the leader in gene control, and Lonza Pharma & Biotech announce a partnership for…

May 16, 2019 Off

Azitra, Inc. Expands Research and Development Team to Support Clinical Development Program

By BusinessWire

Trudy H. Grossman, Ph.D., and Roger Léger, Ph.D., named to executive leadership positions FARMINGTON, Conn.–(BUSINESS WIRE)–Azitra, Inc., a clinical-stage medical…

May 16, 2019 Off

Aimmune to Present at RBC Capital Markets Global Healthcare Conference

By BusinessWire

BRISBANE, Calif.–(BUSINESS WIRE)–Aimmune Therapeutics, Inc. (Nasdaq: AIMT), a biopharmaceutical company developing treatments for life-threatening food allergies, today announced that its Chief…

May 16, 2019 Off

PEP-Therapy Reports Positive Results From GLP-Toxicity Study of PEP-010 Drug Candidate

By BusinessWire

A major step towards clinical trials PARIS–(BUSINESS WIRE)–PEP-Therapy, a biotechnology company developing peptides as targeted therapies for oncology, announces that…

May 16, 2019 Off

Celgene Receives European Commission Approvals for REVLIMID® (lenalidomide) and IMNOVID® (pomalidomide)-based Triplet Combination Regimens for Patients with Multiple Myeloma

By BusinessWire

The European Commission has approved two of Celgene’s IMiD®-based combination regimens: REVLIMID in combination with bortezomib and dexamethasone (RVd) in…

May 16, 2019 Off

U.S. FDA Renews DILIsym Software Licenses

By BusinessWire

U.S. FDA Remains Committed to Streamline & Accelerate Drug Development using Model-Informed Drug Development (MIDD) technology RESEARCH TRIANGLE PARK, N.C.–(BUSINESS…

Posts pagination

Previous 1 … 3,184 3,185 3,186 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine